Recombinant SARS-CoV-2 Spike RBD Fc Chimera, Insect Cells Derived
Recombinant SARS-CoV-2 Spike RBD Fc Chimera, Insect Cells Derived
Product Specifications
Field of Research
Infectious Disease & Virology
Endotoxin
Less than 0.1 EU/ugof rSARS-CoV-2 Spike RBD-Fc as determined by LAL method.
Purity
> 90% by SDS-PAGE.
Bioactivity
Testing in progress.
Form
Lyophilized from a 0.2 μm filtered concentrated solution in PBS, pH 7.0, 5 % Trehalose.
Molecular Weight
Approximately 52.3 kDa as predicted, containing 465 amino acids. On SDS-PAGE, 54 kDa under reducing conditions, and 101.5 kDa as homodimer under non-reducing conditions.
Storage Conditions
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.- 12 months from date of receipt, -20 to -70 °C as supplied.- 1 month, 2 to 8 °C under sterile conditions after reconstitution.- 3 months, -20 to -70 °C under sterile conditions after reconstitution.
Notes
For research use only.
AA Sequence
AGMGRVQPTE SIVRFPNITN LCPFGEVFNA TRFASVYAWN RKRISNCVAD YSVLYNSASF STFKCYGVSP TKLNDLCFTN VYADSFVIRG DEVRQIAPGQ TGKIADYNYK LPDDFTGCVI AWNSNNLDSK VGGNYNYLYR LFRKSNLKPF ERDISTEIYQ AGSTPCNGVE GFNCYFPLQS YGFQPTNGVG YQPYRVVVLS FELLHAPATV CGPKKSTNLV KNKCVNFIEG RMDEPKSSDK THTCPPCPAP EFEGAPSVFL FPPKPKDTLM ISRTPEVTCV VVDVSHEDPE VKFNWYVDGV EVHNAKTKPR EEQYNSTYRV VSVLTVLHQD WLNGKEYKCK VSNKALPTPI EKTISKAKGQ PREPQVYTLP PSRDELTKNQ VSLTCLVKGF YPSDIAVEWE SNGQPENNYK TTPPVLDSDG SFFLYSKLTV DKSRWQQGNV FSCSVMHEAL HNHYTQKSLS LSPGK
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog